FDS supplementation significantly decreased C-reactive protein levels as a biomarker of inflammation ( 2.5 vs. 2.04 mg/l , p < 0.05 ) and lipid peroxidation in the form of MDA ( 3.36 vs. 2.7 nmol/ml , p < 0.05 ) at 6 weeks compared to the baseline .